268 related articles for article (PubMed ID: 3485758)
1. The role of HLA antigens in the manifestation and course of Graves' disease.
Stenszky V; Kozma L; Balazś C; Bear JC; Farid NR
Mol Biol Med; 1986 Feb; 3(1):53-62. PubMed ID: 3485758
[TBL] [Abstract][Full Text] [Related]
2. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers.
Frecker MF; Preus M; Kozma L; Krasrits E; Stenszky V; Balazś C; Farid NR
Mol Biol Med; 1986 Feb; 3(1):63-71. PubMed ID: 3083192
[TBL] [Abstract][Full Text] [Related]
4. HLA and autoimmune endocrine disease 1985.
Farid NR; Thompson C
Mol Biol Med; 1986 Feb; 3(1):85-97. PubMed ID: 3485759
[TBL] [Abstract][Full Text] [Related]
5. A study of human leukocyte D locus related antigens in Graves' disease.
Farid NR; Sampson L; Noel EP; Barnard JM; Mandeville R; Larsen B; Marshall WH; Carter ND
J Clin Invest; 1979 Jan; 63(1):108-13. PubMed ID: 105012
[TBL] [Abstract][Full Text] [Related]
6. Serological and molecular studies of HLA in Sardinian patients with Graves' disease.
La Nasa G; Martino E; Carcassi C; Mulargia M; Floris L; Vacca A; Baldini G; Orrù S; Ledda A; Grasso L
Dis Markers; 1991; 9(6):307-12. PubMed ID: 1823309
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism of the fourth component of complement in Graves' disease and type I diabetes mellitus.
Skanes V; Larsen B; Sampson-Murphy L; Farid NR
Clin Invest Med; 1985; 8(2):126-32. PubMed ID: 3869086
[TBL] [Abstract][Full Text] [Related]
8. HLA-DR associations with Graves' disease in eastern Hungary.
Stenszky V; Kozma L; Balazs C; Farid NR
Clin Invest Med; 1983; 6(3):181-4. PubMed ID: 6580983
[TBL] [Abstract][Full Text] [Related]
9. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus.
Gambelunghe G; Gerli R; Bocci EB; Del Sindaco P; Ghaderi M; Sanjeevi CB; Bistoni O; Bini V; Falorni A
Rheumatology (Oxford); 2005 Mar; 44(3):287-92. PubMed ID: 15522921
[TBL] [Abstract][Full Text] [Related]
10. The genetics of Graves' disease: HLA and disease susceptibility.
Stenszky V; Kozma L; Balázs C; Rochlitz S; Bear JC; Farid NR
J Clin Endocrinol Metab; 1985 Oct; 61(4):735-40. PubMed ID: 3861611
[TBL] [Abstract][Full Text] [Related]
11. Molecular mapping of the HLA class II region in HLA-DR3 associated idiopathic membranous nephropathy.
Sacks SH; Warner C; Campbell RD; Dunham I
Kidney Int Suppl; 1993 Jan; 39():S13-9. PubMed ID: 8096882
[TBL] [Abstract][Full Text] [Related]
12. [HLA typing and insulin antibody production in insulin-dependent diabetics].
Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
[TBL] [Abstract][Full Text] [Related]
13. [Graves' disease. Predominance of the DRw3 antigen (author's transl)].
Allanic H; Fauchet R; Lorcy Y; Heim J; Guéguen M; Leguerrier AM; Genetet B
Nouv Presse Med; 1980 Jun; 9(26):1823-6. PubMed ID: 6893077
[TBL] [Abstract][Full Text] [Related]
14. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles.
Wiencke K; Spurkland A; Schrumpf E; Boberg KM
Hepatology; 2001 Oct; 34(4 Pt 1):625-30. PubMed ID: 11584356
[TBL] [Abstract][Full Text] [Related]
15. HLA haplotypes in familial Graves' disease.
Farid NR; Moens H; Larsen B; Payne R; Saltman K; Fifield F; Ingram DW
Tissue Antigens; 1980 May; 15(5):492-500. PubMed ID: 6893771
[TBL] [Abstract][Full Text] [Related]
16. HLA and Graves' disease: an association with HLA-DRw3.
Allannic H; Fauchet R; Lorcy Y; Heim J; Gueguen M; Leguerrier AM; Genetet B
J Clin Endocrinol Metab; 1980 Oct; 51(4):863-7. PubMed ID: 6932402
[TBL] [Abstract][Full Text] [Related]
17. Graves' ophthalmopathy, eye muscle antibodies and HLA antigens.
Balazs C; Bokk A; Molnar I; Stenszky V; Farid NR
Exp Clin Immunogenet; 1989; 6(2):190-2. PubMed ID: 2629892
[No Abstract] [Full Text] [Related]
18. HLA-A, -B, -C and -DR antigens in patients with Graves' disease and their correlation with signs and clinical course.
Dahlberg PA; Holmlund G; Karlsson FA; Säfwenberg J
Acta Endocrinol (Copenh); 1981 May; 97(1):42-7. PubMed ID: 6164233
[TBL] [Abstract][Full Text] [Related]
19. Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism.
Mäkelä S; Mustonen J; Ala-Houhala I; Hurme M; Partanen J; Vapalahti O; Vaheri A; Pasternack A
J Infect Dis; 2002 Sep; 186(6):843-6. PubMed ID: 12198621
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter.
Schleusener H; Schernthaner G; Mayr WR; Kotulla P; Bogner U; Finke R; Meinhold H; Koppenhagen K; Wenzel KW
J Clin Endocrinol Metab; 1983 Apr; 56(4):781-5. PubMed ID: 6131902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
